Botanical species · safety record

Oplopanax elatus

The EFSA Compendium of Botanicals holds 18 constituent measurements for Oplopanax elatus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Oplopanax elatus (Nakai) Nakai

18Constituent measurements
0Safety records
7Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • P-coumaric acid6
  • Falcarindiol2
  • Pentacyclic triterpene saponins2
  • Polyacetylene derivatives2
  • Saponins2
  • Aloe-emodin1
  • Chrysophanol1
  • Emodin1
  • Physcion1

Plant parts

  • Leaves6
  • Roots and other underground parts6
  • Unspecified4
  • Stem2
  • stalk2

Preparations

  • Solvent extraction12

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
FalcarindiolRoots and other underground partsSolvent extraction≥ 49.87 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
FalcarindiolRoots and other underground partsSolvent extraction≤ 52.07 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Polyacetylene derivativesRoots and other underground partsSolvent extraction≥ 29.89 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Polyacetylene derivativesRoots and other underground partsSolvent extraction≤ 37.69 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Aloe-emodinUnspecifiedUnspecifiedNo resolvable identifier
ChrysophanolUnspecifiedUnspecifiedNo resolvable identifier
EmodinUnspecifiedUnspecifiedNo resolvable identifier
P-coumaric acidLeavesSolvent extraction≤ 170.7 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
P-coumaric acidRoots and other underground partsSolvent extraction≥ 36.4 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
P-coumaric acidStem / stalkSolvent extraction≤ 1114.7 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
P-coumaric acidStem / stalkSolvent extraction≥ 98.1 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
P-coumaric acidRoots and other underground partsSolvent extraction≤ 819.4 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
P-coumaric acidLeavesSolvent extraction≥ 87.5 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Pentacyclic triterpene saponinsLeavesSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
Pentacyclic triterpene saponinsLeavesSolvent extractionChromatographic testsNo resolvable identifier
PhyscionUnspecifiedUnspecifiedNo resolvable identifier
SaponinsLeavesStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
SaponinsLeavesStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Wang, GS., Xu, JD., Ma, XL., Sun, YX., Liu, JZ., Murayama, T., Shoji, J. Chemical studies on the glycosides in the leaves of Oplopanax elatus Nakai .4.. CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 1997, vol. 13, no. 1, p. 34-38.
  2. Kim, Jun Heong. Assessment on Antioxidant Properties of Oplopanax elatus Nakai in vitro. KOREAN JOURNAL OF MEDICINAL CROP SCIENCE, 2007, vol. 15, no. 2, p. 112-119.
  3. Wang Guang-shu., Yang Xiao-Hong., Xu Jing-da. Structures of four new triterpenoid saponins from the leaves of Oplopanax elatus Nakai. Yaoxue Xuebao, 2004, vol. 39, no. 5, p. 354-358.
  4. Xu, Song., Liang, Huaqing. Studies on anthraquinones of Tall oplopanax (Oplopanax elatus). Zhongcaoyao, 1998, p. 222-223.
  5. Huang, Weihua., Yang, Jing., Zhao, Jing., Wang, Chong-zhi., Yuan, Chun-su., Li, Shao-ping. Quantitative analysis of six polyynes and one polyene in Oplopanax horridus and Oplopanax elatus by pressurized liquid extraction and on-line SPE-HPLC. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, vol. 53, no. 4, p. 906-910. DOI
  6. Wang, G. S., Chen, Y. P., Xu, J. D., Murayama, T., Shoji, J. Isolation and structure elucidation of cirensenosides O and P from the leaves of Oplopanax elatus Nakai . Yaoxue xuebao, 1996, vol. 31, no. 12, p. 940-944.
  7. Wang, G., Meng, Q., Xu, J. Glycosides in the leaves of Oplopanax elatus Nakai. Chinese pharmaceutical journal, 1996, vol. 31, no. 9, p. 523-524.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue